Document is current
Any future updates will be listed below
-
Authors
He, Xin-Yu
Wang, Jia-Qi
Chen, Yao
Yuan, Ting-Xun
Zhao, Xiang
Sun, Yi-Jing
Liu, Yi-Ming
Wang, Zhong-Yan
Cai, Yan-Bing
Gao, Wei
Cui, Chun-Ping
Yi, Zheng-Jun
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (81802054)
Youth Innovation Technology in Colleges and Universities of Shandong Province of China (2021KJ106)
Tai-Shan Scholar Program from Shandong Province (tsqn202103116)
Natural Science Foundation of Shandong Province (ZR2022MH061)
Innovation Entrepreneurship Training Program for College Students of Shandong Province (S202410438028)
Program for Innovation Team Building at Institutions of Higher Education in Chongqing Municipality (no)
Science and Technology Development Program, Weifang, China (2024GX011)
Graduate Student Research Grant from Shandong Second Medical University (2024YJSCX020)
- License Information
-
More Information
Article History
Received: 25 January 2025
Accepted: 19 August 2025
First Online: 29 August 2025
Declarations
:
: For animal experiments, the study entitled ‘The role and molecular mechanism of PK34 modified mesenchymal stem cells in the treatment of tuberculosis’ was approved by the Medical Ethics Committee of Shandong Second Medical University (Date: 02.28.2018, No. 075) and performed according to the AVMA guidelines. All experimental procedures were conducted in strict accordance with ethical standards for animal research. This research did not involve the use of any human cells, tissues, samples, or cell lines.
: Not applicable.
: The authors declare that they have no competing interests.
: The authors declare that they have not use AI-generated work in this manuscript.
